Hitachi vs Roche: Founders, CEOs and History
Hitachi was founded in 1910 by Namihei Odaira and is led by Toshiaki Tokunaga. Roche was founded in 1896 by Fritz Hoffmann-La Roche and is led by Thomas Schinecker.
Company facts
Founders
Hitachi
Namihei Odaira
Hitachi possesses a historic, foundational founding story, rooted in the industrialization of early 20th-century Japan and driven by a nationalist obsession with technological independence.
Roche
Fritz Hoffmann-La Roche
Fritz Hoffmann-La Roche (1868-1920) founded F. Hoffmann-La Roche & Co. in Basel on 1 October 1896, at age 28.
CEOs and their tenures
Hitachi
- Toshiaki Higashihara2016–2022
Former President and Chief Executive Officer
Shifted Hitachi from a sprawling conglomerate toward infrastructure and digital businesses.
Source - Keiji Kojima2022–2025
Executive Chairman (CEO 2022-2025)
Finished much of the portfolio cleanup and handed over a more focused group to Tokunaga.
Source - Toshiaki Tokunaga2025–present
President and Chief Executive Officer
Brings an energy and rail background to the top job as Hitachi Energy and Hitachi Rail drive more of the group's growth.
Source
Roche
- Severin Schwan2008–2023
Chief Executive Officer
Serving as CEO from 2008 to 2023, he cemented Roche's absolute dominance in global oncology and highly advanced diagnostics before moving to Chairman of the Board.
Source - Thomas Schinecker2023–present
Chief Executive Officer
Under Schinecker, Roche returned to growth after the COVID testing decline: 2025 sales rose 7% at constant rates to ~$73.8 billion (CHF 61.5 billion) and 12 late-stage studies read out positively that year.
Source
Timeline: Hitachi and Roche side by side
1896Roche
F. Hoffmann-La Roche Founded in Basel
Fritz Hoffmann-La Roche founds the enterprise in Basel, Switzerland, pioneering mass-manufactured, chemically standardized prescription pharmaceuticals.
1898Roche
Commercial Breakthrough with Sirolin
Roche launches non-prescription cough syrup Sirolin, achieving widespread international distribution and financing early clinical laboratories.
1910Hitachi
Founding and First Induction Motor
Namihei Odaira establishes the machinery repair shop that becomes Hitachi, and develops Japan's first 5-horsepower induction motor, establishing the foundation for the company's dominance in electrical engineering.
1932Hitachi
Expansion into Railway Technology
Hitachi begins manufacturing electric locomotives and rail signaling systems, establishing a deep, institutionalized relationship with the Japanese national railway network that would evolve into the modern Hitachi Rail division.
1934Roche
First Industrial Synthesis of Vitamin C
Roche becomes the first company to mass-produce synthetic Vitamin C (Redoxon) at industrial scale, anchoring decades of high-margin global cash flow.
1959Hitachi
Entry into Computing and Electronics
Hitachi develops its first electronic computer, the HITAC, marking the company's strategic entry into the information technology sector and laying the groundwork for its future digital systems business.
1963Roche
Launch of Valium (Diazepam)
Roche introduces Valium, which becomes the world's most widely prescribed psychotropic medication and establishes global pharmaceutical leadership.
1968Roche
Establishment of Roche Diagnostics
Roche launches its dedicated diagnostic division, laying the foundation to become the world's preeminent in-vitro diagnostics (IVD) provider.
2008Roche
Severin Schwan becomes CEO
Severin Schwan became CEO of F. Hoffmann-La Roche in 2008. Led Roche for 14 years; handed over to Thomas Schinecker in March 2023 and became chairman.
2009Roche
Full Acquisition of Genentech for $46.8 Billion
Roche completes its historic $46.8 billion buyout of American biotechnology pioneer Genentech, securing market leadership in oncology biologics.
2016Hitachi
Toshiaki Higashihara becomes CEO
Toshiaki Higashihara became CEO of Hitachi in 2016. Shifted Hitachi from a sprawling conglomerate toward infrastructure and digital businesses.
2018Roche
Foundation Medicine & Flatiron Health Acquisitions
Roche acquires Foundation Medicine and Flatiron Health, integrating real-world oncology data analytics and genomic profiling into personalized healthcare.
2020Hitachi
Acquisition of ABB's Power Grids Business
Hitachi executes the $11 billion acquisition of ABB's Power Grids business, renaming it Hitachi Energy and instantly establishing the company as the global leader in HVDC transmission and grid infrastructure.
2021Hitachi
Acquisition of GlobalLogic
The company acquires the global digital engineering firm GlobalLogic for $9.6 billion, instantly establishing Hitachi as a top-tier provider of advanced software and product design services for the automotive and telecommunications sectors.
2022Hitachi
Hitachi Construction Machinery Stake Sale
Hitachi sold a controlling stake in Hitachi Construction Machinery to Itochu and Japan Industrial Partners, part of its exit from cyclical listed subsidiaries.
2023Roche
Acquired Telavant
F. Hoffmann-La Roche acquired Telavant for $7.1 billion. Roche paid $7.1 billion upfront for Telavant to gain US and Japan rights to the anti-TL1A antibody RVT-3101 (afimkibart) for inflammatory bowel disease.
2024Hitachi
Acquired Thales Ground Transportation Systems
Hitachi acquired Thales Ground Transportation Systems. Hitachi Rail completed its ~$1.88 billion (EUR 1.66 billion) acquisition of Thales's Ground Transportation Systems business, its rail signalling division, expanding Hitachi Rail to 51 countries and shiftin…
2025Hitachi
Toshiaki Tokunaga Becomes CEO
Toshiaki Tokunaga became President and CEO on April 1, 2025, succeeding Keiji Kojima, who became Executive Chairman.
2025Roche
Group Sales Reach CHF 61.5 Billion
Under CEO Thomas Schinecker, Roche delivers group sales of ~$73.8 billion (CHF 61.5 billion), driven by ~$57.2B (CHF 47.7B) in Pharmaceuticals and ~$16.6B (CHF 13.8B) in Diagnostics.
2026Hitachi
Record Results and Home Appliance Sale
Hitachi reported record FY2025 profit in April 2026 and agreed to sell 80.1% of its home appliance business to Nojima for about $737 million (¥110 billion).
Acquisitions
Hitachi
- Thales Ground Transportation Systems2024Undisclosed
- GlobalLogic2021Undisclosed
- ABB Power Grids2020Undisclosed
Roche
- PathAI2026$1.1B
- 89bio2025$3.5B
- Telavant2023$7.1B
- Carmot Therapeutics2023$2.7B
- Foundation Medicine2018$2.4B
- ForSight VISION42017Undisclosed
Questions about Hitachi vs Roche
Who is the CEO of Hitachi, Ltd. and F. Hoffmann-La Roche AG?
Hitachi, Ltd. is led by Toshiaki Tokunaga and F. Hoffmann-La Roche AG is led by Thomas Schinecker. Both serve as the top executive responsible for the company's strategy, operations, and financial performance.
When was Hitachi, Ltd. founded vs F. Hoffmann-La Roche AG?
F. Hoffmann-La Roche AG was founded in 1896 — 14 years before Hitachi, Ltd., which was founded in 1910. F. Hoffmann-La Roche AG's longer operating history gives it a deeper track record but also potentially more institutional inertia compared to the younger Hitachi, Ltd..
How many employees does Hitachi, Ltd. have compared to F. Hoffmann-La Roche AG?
Hitachi, Ltd. employs approximately 287,901 people, while F. Hoffmann-La Roche AG employs approximately 112,774. Hitachi, Ltd. has the larger workforce at 287,901 employees, compared to F. Hoffmann-La Roche AG's 112,774. A higher headcount does not necessarily imply greater efficiency — it often reflects differences in business model (e.g., manufacturing vs. software).
Where are Hitachi, Ltd. and F. Hoffmann-La Roche AG headquartered?
Hitachi, Ltd. is headquartered in Japan and F. Hoffmann-La Roche AG is headquartered in Switzerland. Their different home markets mean they may face different regulatory frameworks, tax regimes, and currency exposure.
Who founded Hitachi, Ltd. and F. Hoffmann-La Roche AG?
Hitachi, Ltd. was founded by Namihei Odaira. F. Hoffmann-La Roche AG was founded by Fritz Hoffmann-La Roche.
Which company has a longer operating history — Hitachi, Ltd. or F. Hoffmann-La Roche AG?
F. Hoffmann-La Roche AG has been operating for approximately 130 years, making it the more established of the two companies. Hitachi, Ltd. has been in operation for around 116 years. A longer operating history often signals greater institutional resilience and brand recognition, though it can also mean slower adaptation to new market conditions.
Figures come from each company's filings and the sources linked beside them. Amounts reported in another currency are shown in US dollars at an approximate rate and marked with ~. Back to the Hitachi vs Roche overview